Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.035
+0.015 (1.47%)
Apr 23, 2026, 1:16 PM EDT - Market open
Genprex Market Cap
Genprex has a market cap or net worth of $9.53 million as of April 23, 2026. Its market cap has increased by 27.04% in one year.
Market Cap
9.53M
Enterprise Value
1.93M
1-Year Change
27.04%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $9.53M, a decrease of -15.68%. That is a compound annual growth rate of -2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 9.20M | 130.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 11.37M |
| Quoin Pharmaceuticals | 11.27M |
| Aprea Therapeutics | 11.23M |
| Kiora Pharmaceuticals | 11.06M |
| Silo Pharma | 10.84M |
| CalciMedica | 10.42M |
| Bolt Biotherapeutics | 9.90M |
| Evogene | 9.77M |